Gi Windows, Inc.
Clinical trials sponsored by Gi Windows, Inc., explained in plain language.
-
New device aims to make weight loss surgery safer and more effective
Disease control OngoingThis study tests a new tool called the SFM Anastomosis Device, used during weight loss surgery to connect parts of the intestine. It includes 28 adults with severe obesity (BMI 35-55) who are either having a first-time sleeve gastrectomy with an added intestinal bypass, or have h…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Gut reroute surgery shows promise for diabetes control
Disease control OngoingThis study tests a procedure that reroutes part of the small intestine to help control blood sugar in people with type 2 diabetes and obesity. About 15 participants with a BMI between 30 and 50 will be followed for one year to see changes in HbA1c and weight. The goal is to impro…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC